Long COVID-19 “A Metabolic Sequela,” the New-Onset Diabetes among Cohorts Admitted at Tertiary Care Hospital, Hyderabad

Author:

Bala Sudha1,Darivemula Surendra B1,Muralidharan Shrikanth2,Bandaru Rajiv K3,Katkuri Sushma N4,Singireddy Anesha1

Affiliation:

1. Community Medicine, ESIC Medical College, Hyderabad, India

2. Public Health Consultant, Pune, India

3. General Medicine, ESIC Medical College, Hyderabad, India

4. Community Medicine, Malla Reddy Institute of Medical Sciences, Hyderabad, India

Abstract

Abstract Introduction: Long COVID is now being encountered by many individuals during this pandemic. It is best diagnosed by a history consistent with acute COVID-19 followed by a prolonged recovery. Aim: This study was undertaken to detect new-onset diabetes mellitus among COVID cohorts and their associated factors. Materials and Methods: A total of 152 COVID-19 patients admitted at ESIC medical college and hospital without a known history of diabetes mellitus were included in the study. Data were collected about sociodemographic variables, their symptoms at presentation, lifestyle determinants, and measurement of blood sugar by HbA1C for a period of 6 months follow-up with three readings (baseline, third month, and sixth month) using a predesigned and pre-tested questionnaire schedule. Results: Mean HbA1c was found to be 7.28 ± 2.09 at the third reading with new-onset diabetes mellitus development among 38 (25%). There was a positive correlation between age and mean HbA1c measurement on follow-up. Significant risk factors were the presence of comorbidities OR = 15.23 (4.42–22.46), sedentary lifestyle 6.14 (1.39–9.11), tobacco usage 6.80 (2.63–14.55), symptomatic COVID-19 presentation 2.43 (1.11–5.41), alcohol usage 2.11 (0.99–4.49) and extra physical activity 1.72 (0.66–2.32). Conclusions: There was a quarter of patients with new-onset diabetes mellitus in the present study. This will help us to identify the risk factors of this sequela at the earliest for initiating preventive strategies at the primary care level.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3